ArticleJornal vascular brasileiro2026
Vascular access in Pará: clinical and epidemiological aspects of patients on renal replacement therapy at the largest specialist center in Pará state, Brazil.
Article in Jornal vascular brasileiro, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There are no official data on the prevalence of end-stage chronic kidney disease with dialysis for the Brazilian state of Pará. Objectives: To describe the clinical-epidemiological profile of hemodialysis patients at the largest specialist center in the state of Pará. Methods: This is an observational, cross-sectional, descriptive, quantitative study. Simple descriptive statistics were calculated. Data were collected from medical records from June to August 2022 at the Hemodialysis Center at the Hospital de Clínicas Gaspar Vianna (HCGV) and the Monteiro Leite Hemodialysis Clinic (CMHL), both in Belém, Pará, Brazil. A total of 191 patients from the chronic hemodialysis program were interviewed. Results: Of the total sample, 28.8% patients were from HCGV and 71.6% from CHML; 57.1% were men and 42.9% were women. Mean age was 54.1 years. Results showed that 65.4% of patients self-reported skin color as brown, 44.5% had completed primary education, 41.9% were single, 71.4% had hypertension, 40.6% had diabetes, and 77.5% had been on renal replacement therapy for a mean time of 4 years. Regarding treatment, 86.9% started treatment with a short-duration catheter, 8.4% were using a long-dwelling catheter, and 4.7% had a definitive dialysis access via a mature arteriovenous fistula (AVF). Currently, 58.1% of these patients have a native AVF, 34% have a long-dwelling catheter, and 3.1% have a short-duration catheter and no AVF. Conclusions: Patients on renal replacement therapy in Pará predominantly initiate hemodialysis in an unplanned manner, using temporary venous catheters, although they transition to definitive vascular access over time. This scenario highlights the need for early diagnosis of chronic kidney disease and timely vascular access planning, aiming to reduce complications and optimize clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.